PALATIN TECHNOLOGIES, INC. Increase (Decrease) in Accounts Receivable
PALATIN TECHNOLOGIES, INC. (PTN) reported Increase (Decrease) in Accounts Receivable of $1.64 million for the 6-month period ending 2025-12-31, per its 10-Q filed 2026-02-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-02-17
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$5.25M.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $6.89M.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accounts receivable for fiscal 2025 was $0.00.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accounts receivable for fiscal 2024 was -$2.92M.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$1.14M.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in accounts receivable for fiscal 2022 was -$199.58K, a 112.63% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$5.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | $1.64M 10-Q · filed 2026-02-17 | $1.64M derived: sum of 3 quarters · filed 2026-02-17 | $1.64M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2025-09-30 | $6.89M 10-Q · filed 2025-11-14 | $6.89M derived: sum of 2 quarters · filed 2025-11-14 | $6.89M derived: sum of 3 quarters · filed 2025-11-14 | $6.89M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $0.00 derived: sum of 2 quarters · filed 2025-09-23 | $0.00 derived: sum of 3 quarters · filed 2025-09-23 | $0.00 10-K · filed 2025-09-23 | ||||
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-05-14 | $0.00 10-Q · filed 2025-05-14 | $0.00 derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $0.00 10-Q · filed 2025-02-13 | $0.00 derived: sum of 3 quarters · filed 2025-11-14 | -$2.35M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | -$2.35M derived: sum of 3 quarters · filed 2025-11-14 | -$4.48M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | -$2.35M derived: sum of 2 quarters · filed 2025-09-23 | -$4.48M derived: sum of 3 quarters · filed 2025-09-23 | -$2.92M 10-K · filed 2025-09-23 | $2.92M 10-K · filed 2024-09-30 | |||
| 2024-03-31 | -$2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | -$4.48M derived: sum of 2 quarters · filed 2025-05-14 | -$2.92M 10-Q · filed 2025-05-14 | $2.92M 10-Q · filed 2024-05-15 | -$4.13M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -$2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | -$569.60K 10-Q · filed 2025-02-13 | $569.60K 10-Q · filed 2024-02-14 | -$1.79M derived: sum of 3 quarters · filed 2025-02-13 | -$1.68M derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-09-30 | $1.57M 10-Q · filed 2024-11-14 | $350.61K derived: sum of 2 quarters · filed 2024-11-14 | $458.49K derived: sum of 3 quarters · filed 2024-11-14 | $674.25K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | -$1.11M derived: sum of 2 quarters · filed 2024-09-30 | -$893.01K derived: sum of 3 quarters · filed 2024-09-30 | -$1.14M 10-K · filed 2024-09-30 | ||||
| 2023-03-31 | $107.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $323.64K derived: sum of 2 quarters · filed 2024-05-15 | $80.91K 10-Q · filed 2024-05-15 | -$80.91K 10-Q · filed 2023-05-15 | $671.77K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $215.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | -$26.97K 10-Q · filed 2024-02-14 | $26.97K 10-Q · filed 2023-02-14 | $563.89K derived: sum of 3 quarters · filed 2024-02-14 | $769.90K derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2022-09-30 | -$242.73K 10-Q · filed 2023-11-14 | $348.13K derived: sum of 2 quarters · filed 2023-11-14 | $554.14K derived: sum of 3 quarters · filed 2023-11-14 | -$1.11M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $590.86K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $796.88K derived: sum of 2 quarters · filed 2023-09-28 | -$866.00K derived: sum of 3 quarters · filed 2023-09-28 | -$199.58K 10-K · filed 2023-09-28 | $199.58K 10-K · filed 2022-09-22 | |||
| 2022-03-31 | $206.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | -$1.46M derived: sum of 2 quarters · filed 2023-05-15 | -$790.44K 10-Q · filed 2023-05-15 | $790.44K 10-Q · filed 2022-05-16 | $2.66M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -$1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | -$996.45K 10-Q · filed 2023-02-14 | $2.45M derived: sum of 3 quarters · filed 2023-02-14 | $137.37K derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-09-30 | $666.43K 10-Q · filed 2022-11-14 | $4.12M derived: sum of 2 quarters · filed 2022-11-14 | $1.80M derived: sum of 3 quarters · filed 2022-11-14 | $2.99M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $3.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $1.13M derived: sum of 2 quarters · filed 2022-09-22 | $2.32M derived: sum of 3 quarters · filed 2022-09-22 | $1.58M 10-K · filed 2022-09-22 | -$1.58M 10-K · filed 2021-09-28 | |||
| 2021-03-31 | -$2.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | -$1.12M derived: sum of 2 quarters · filed 2022-05-16 | -$1.87M 10-Q · filed 2022-05-16 | $1.87M 10-Q · filed 2021-05-14 | $118.66M derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $446.62K 10-Q · filed 2022-02-14 | $120.98M derived: sum of 3 quarters · filed 2022-02-14 | $120.86M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-09-30 | -$744.37K 10-Q · filed 2021-11-15 | $744.37K 10-Q · filed 2020-11-16 | $119.79M derived: sum of 2 quarters · filed 2021-11-15 | $119.67M derived: sum of 3 quarters · filed 2021-11-15 | $119.69M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $120.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $120.41M derived: sum of 2 quarters · filed 2021-09-28 | $120.43M derived: sum of 3 quarters · filed 2021-09-28 | $60.27M 10-K · filed 2021-09-28 | ||||
| 2020-03-31 | -$117.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | -$97.38K derived: sum of 2 quarters · filed 2021-05-14 | -$60.27M 10-Q · filed 2021-05-14 | -$120.53M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $20.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | -$60.15M 10-Q · filed 2021-02-16 | -$120.41M derived: sum of 3 quarters · filed 2021-02-16 | -$120.41M derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | -$60.17M 10-Q · filed 2020-11-16 | -$120.43M derived: sum of 2 quarters · filed 2020-11-16 | -$120.43M derived: sum of 3 quarters · filed 2020-11-16 | -$120.54M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | -$60.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | -$60.27M derived: sum of 2 quarters · filed 2020-09-25 | -$60.37M derived: sum of 3 quarters · filed 2020-09-25 | -$60.27M 10-K · filed 2020-09-25 | ||||
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | -$104.19K derived: sum of 2 quarters · filed 2020-05-11 | $0.00 10-Q · filed 2020-05-11 | $30.23M derived: sum of 4 quarters · filed 2020-09-25 | ||||
| 2018-12-31 | -$104.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-10 | $0.00 10-Q · filed 2020-02-10 | $30.23M derived: sum of 3 quarters · filed 2020-09-25 | $30.23M derived: sum of 4 quarters · filed 2020-09-25 | ||||
| 2018-09-30 | $104.19K 10-Q · filed 2019-11-12 | $30.34M derived: sum of 2 quarters · filed 2020-09-25 | $30.34M derived: sum of 3 quarters · filed 2020-09-25 | $20.95M derived: sum of 4 quarters · filed 2020-09-25 | ||||
| 2018-06-30 | $30.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | $30.23M derived: sum of 2 quarters · filed 2020-09-25 | $20.84M derived: sum of 3 quarters · filed 2020-09-25 | $15.12M 10-K · filed 2020-09-25 | ||||
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | -$9.39M derived: sum of 2 quarters · filed 2019-05-09 | -$15.12M 10-Q · filed 2019-05-09 | -$34.89M derived: sum of 4 quarters · filed 2019-09-12 | ||||
| 2017-12-31 | -$9.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-11 | -$15.12M 10-Q · filed 2019-02-11 | -$34.89M derived: sum of 3 quarters · filed 2019-09-12 | -$30.23M derived: sum of 4 quarters · filed 2019-09-12 | ||||
| 2017-09-30 | -$5.73M 10-Q · filed 2018-11-09 | -$25.50M derived: sum of 2 quarters · filed 2019-09-12 | -$20.84M derived: sum of 3 quarters · filed 2019-09-12 | -$20.84M derived: sum of 4 quarters · filed 2019-09-12 | ||||
| 2017-06-30 | -$19.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12 | -$15.12M derived: sum of 2 quarters · filed 2019-09-12 | -$15.12M derived: sum of 3 quarters · filed 2019-09-12 | -$15.12M 10-K · filed 2019-09-12 | ||||
| 2017-03-31 | $4.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $4.66M derived: sum of 2 quarters · filed 2018-05-14 | $4.66M 10-Q · filed 2018-05-14 | -$4.66M 10-Q · filed 2017-05-15 | $4.66M derived: sum of 4 quarters · filed 2018-09-13 | |||
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-12 | $0.00 10-Q · filed 2018-02-12 | $0.00 derived: sum of 3 quarters · filed 2018-09-13 | $0.00 derived: sum of 4 quarters · filed 2018-09-13 | ||||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-09-13 | $0.00 derived: sum of 3 quarters · filed 2018-09-13 | |||||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-13 | $0.00 derived: sum of 2 quarters · filed 2018-09-13 | $0.00 10-K · filed 2018-09-13 | |||||
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | $0.00 10-Q · filed 2017-05-15 | ||||||
| 2015-12-31 | $0.00 10-Q · filed 2016-02-12 | |||||||
| 2015-06-30 | $0.00 10-K · filed 2017-09-25 | |||||||
| 2014-12-31 | $3.04M 10-Q · filed 2016-02-12 | |||||||
| 2014-06-30 | $0.00 10-K · filed 2015-09-18 | |||||||
| 2013-12-31 | $0.00 10-Q · filed 2015-02-12 | |||||||
| 2013-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-18 | -$37.99K derived: sum of 2 quarters · filed 2015-09-18 | -$31.44K derived: sum of 3 quarters · filed 2015-09-18 | -$27.63K 10-K · filed 2015-09-18 | ||||
| 2013-03-31 | -$37.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | -$31.44K derived: sum of 2 quarters · filed 2014-05-12 | -$27.63K 10-Q · filed 2014-05-12 | -$16.60K derived: sum of 4 quarters · filed 2014-09-12 | ||||
| 2012-12-31 | $6.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | $10.36K 10-Q · filed 2014-02-14 | $21.39K derived: sum of 3 quarters · filed 2014-09-12 | -$1.03M derived: sum of 4 quarters · filed 2014-09-12 | ||||
| 2012-09-30 | $3.81K 10-Q · filed 2013-11-13 | -$3.81K 10-Q · filed 2012-11-14 | $14.84K derived: sum of 2 quarters · filed 2014-09-12 | -$1.04M derived: sum of 3 quarters · filed 2014-09-12 | -$230.86K derived: sum of 4 quarters · filed 2014-09-12 | |||
| 2012-06-30 | $11.03K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-12 | -$1.04M derived: sum of 2 quarters · filed 2014-09-12 | -$234.67K derived: sum of 3 quarters · filed 2014-09-12 | -$103.52K 10-K · filed 2014-09-12 | $103.52K 10-K · filed 2012-09-10 | |||
| 2012-03-31 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-13 | -$245.70K derived: sum of 2 quarters · filed 2013-05-13 | -$114.55K 10-Q · filed 2013-05-13 | $114.55K 10-Q · filed 2012-05-14 | $10.84K derived: sum of 4 quarters · filed 2013-09-27 | |||
| 2011-12-31 | $805.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-13 | $937.08K 10-Q · filed 2013-02-13 | -$937.08K 10-Q · filed 2012-02-14 | $1.06M derived: sum of 3 quarters · filed 2013-09-27 | $1.06M derived: sum of 4 quarters · filed 2013-09-27 | |||
| 2011-09-30 | $131.15K 10-Q · filed 2012-11-14 | $256.54K derived: sum of 2 quarters · filed 2013-09-27 | $256.54K derived: sum of 3 quarters · filed 2013-09-27 | $784.76K derived: sum of 4 quarters · filed 2013-09-27 | ||||
| 2011-06-30 | $125.39K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27 | $125.39K derived: sum of 2 quarters · filed 2013-09-27 | $653.61K derived: sum of 3 quarters · filed 2013-09-27 | $128.27K 10-K · filed 2013-09-27 | -$128.27K 10-K · filed 2012-09-10 | |||
| 2011-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-14 | $528.22K derived: sum of 2 quarters · filed 2012-05-14 | $2.88K 10-Q · filed 2012-05-14 | |||||
| 2010-12-31 | $528.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14 | $2.88K 10-Q · filed 2012-02-14 | ||||||
| 2010-09-30 | -$525.34K 10-Q · filed 2011-11-14 | |||||||
| 2010-06-30 | $505.65K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |